Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Analytical Method Development V 2.0

Analytical Method Development: SOP for Bridging Study Between Two Analytical Methods – V 2.0

Posted on By

To establish a procedure for conducting a bridging study between an existing validated analytical method and a newly developed or revised method to demonstrate equivalency and justify method replacement or parallel usage.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Comparative Evaluation of Transferred Methods – V 2.0

Posted on By

To define a structured procedure for conducting comparative evaluations of analytical methods following their transfer between laboratories to confirm reproducibility, accuracy, and equivalency across units.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Troubleshooting Transferred Methods – V 2.0

Posted on By

To establish a structured and systematic procedure for identifying, documenting, investigating, and resolving analytical issues encountered during or after the transfer of validated analytical methods between laboratories.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Documentation for Method Transfer Approval – V 2.0

Posted on By

To provide a structured approach for the documentation and approval process associated with the transfer of validated analytical methods from the sending unit (SU) to the receiving unit (RU). This ensures compliance with regulatory expectations and internal quality standards.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Transfer of Microbiological Analytical Methods – V 2.0

Posted on By

To define the procedure for transferring validated microbiological analytical methods from a sending laboratory (SU) to a receiving laboratory (RU), including aseptic technique verification, method equivalency assessment, and documentation requirements.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Qualification of Receiving Laboratory – V 2.0

Posted on By

To establish a standard procedure for the qualification of a Receiving Laboratory (RL) prior to the transfer of analytical methods from a Sending Laboratory (SL), ensuring that the RL is technically competent, adequately equipped, and compliant with regulatory and GMP requirements.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Preparation of Transfer Report and Summary – V 2.0

Posted on By

The purpose of this SOP is to define the process for preparing a comprehensive Transfer Report and Summary following the successful completion of analytical method transfer exercises. This includes data compilation, result evaluation, interpretation of acceptance criteria, deviation handling, and documentation to ensure regulatory compliance and traceability.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Preparation of Transfer Report and Summary – V 2.0

Posted on By

The purpose of this SOP is to define the process for preparing a comprehensive Transfer Report and Summary following the successful completion of analytical method transfer exercises. This includes data compilation, result evaluation, interpretation of acceptance criteria, deviation handling, and documentation to ensure regulatory compliance and traceability.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Investigation of Method Transfer Failures – V 2.0

Posted on By

This SOP defines a systematic approach for investigating failures encountered during analytical method transfer exercises. The goal is to identify the root cause, implement appropriate corrective and preventive actions (CAPA), and document the findings in a manner that ensures regulatory compliance, data integrity, and traceability.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for In-Process Blend Assay Method Development – V 2.0

Posted on By

This SOP defines the procedure for developing, optimizing, and validating in-process blend assay methods. These methods are used to determine assay and uniformity of active pharmaceutical ingredients (APIs) in blending stages prior to tablet compression or capsule filling. It ensures content consistency, quality control, and compliance with regulatory requirements.
Click to read the full article.

Analytical Method Development V 2.0

Posts pagination

Previous 1 … 28 29 30 … 38 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme